Estimating transmission dynamics and serial interval of the first wave of COVID-19 infections under different control measures: a statistical analysis in Tunisia from February 29 to May 5, 2020.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
02 Dec 2020
Historique:
received: 23 05 2020
accepted: 03 11 2020
entrez: 3 12 2020
pubmed: 4 12 2020
medline: 15 12 2020
Statut: epublish

Résumé

Describing transmission dynamics of the outbreak and impact of intervention measures are critical to planning responses to future outbreaks and providing timely information to guide policy makers decision. We estimate serial interval (SI) and temporal reproduction number (R We collected data of investigations and contact tracing between March 1, 2020 and May 5, 2020 as well as illness onset data during the period February 29-May 5, 2020 from National Observatory of New and Emerging Diseases of Tunisia. Maximum likelihood (ML) approach is used to estimate dynamics of R Four hundred ninety-one of infector-infectee pairs were involved, with 14.46% reported pre-symptomatic transmission. SI follows Gamma distribution with mean 5.30 days [95% Confidence Interval (CI) 4.66-5.95] and standard deviation 0.26 [95% CI 0.23-0.30]. Also, we estimated large changes in R Overall, our findings highlight contribution of interventions to interrupt transmission of SARS-CoV-2 in Tunisia.

Sections du résumé

BACKGROUND BACKGROUND
Describing transmission dynamics of the outbreak and impact of intervention measures are critical to planning responses to future outbreaks and providing timely information to guide policy makers decision. We estimate serial interval (SI) and temporal reproduction number (R
METHODS METHODS
We collected data of investigations and contact tracing between March 1, 2020 and May 5, 2020 as well as illness onset data during the period February 29-May 5, 2020 from National Observatory of New and Emerging Diseases of Tunisia. Maximum likelihood (ML) approach is used to estimate dynamics of R
RESULTS RESULTS
Four hundred ninety-one of infector-infectee pairs were involved, with 14.46% reported pre-symptomatic transmission. SI follows Gamma distribution with mean 5.30 days [95% Confidence Interval (CI) 4.66-5.95] and standard deviation 0.26 [95% CI 0.23-0.30]. Also, we estimated large changes in R
CONCLUSIONS CONCLUSIONS
Overall, our findings highlight contribution of interventions to interrupt transmission of SARS-CoV-2 in Tunisia.

Identifiants

pubmed: 33267823
doi: 10.1186/s12879-020-05577-4
pii: 10.1186/s12879-020-05577-4
pmc: PMC7708891
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

914

Références

J Med Virol. 2020 Jun;92(6):645-659
pubmed: 32141624
Am J Epidemiol. 2004 Sep 15;160(6):509-16
pubmed: 15353409
Euro Surveill. 2015 Jun 25;20(25):7-13
pubmed: 26132767
Emerg Infect Dis. 2006 Jan;12(1):110-3
pubmed: 16494726
Ann Intern Med. 2020 Sep 1;173(5):362-367
pubmed: 32491919
Int J Infect Dis. 2020 Apr;93:284-286
pubmed: 32145466
Epidemics. 2019 Dec;29:100356
pubmed: 31624039
PLoS Negl Trop Dis. 2017 Aug 25;11(8):e0005844
pubmed: 28841642
Epidemiology. 2009 May;20(3):344-7
pubmed: 19279492
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415
pubmed: 32271722
Am J Epidemiol. 2013 Nov 1;178(9):1505-12
pubmed: 24043437
Epidemiol Perspect Innov. 2010 Dec 15;7:12
pubmed: 21159178
Science. 2003 Jun 20;300(5627):1966-70
pubmed: 12766207
Sci Total Environ. 2020 Jul 1;724:138201
pubmed: 32408450
PLoS Comput Biol. 2018 Dec 17;14(12):e1006554
pubmed: 30557340
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Infect Chemother. 2016 Jun;48(2):99-107
pubmed: 27433380
Emerg Infect Dis. 2020 Jun;26(6):1341-1343
pubmed: 32191173

Auteurs

Khouloud Talmoudi (K)

National Observatory of New and Emerging Diseases, Tunis, Tunisia. talmoudi.khouloud@gmail.com.
Research laboratory "Epidemiology and Prevention of Cardiovascular Diseases in Tunisia", Tunis, Tunisia. talmoudi.khouloud@gmail.com.

Mouna Safer (M)

National Observatory of New and Emerging Diseases, Tunis, Tunisia.
Research laboratory "Epidemiology and Prevention of Cardiovascular Diseases in Tunisia", Tunis, Tunisia.

Hejer Letaief (H)

National Observatory of New and Emerging Diseases, Tunis, Tunisia.
Research laboratory "Epidemiology and Prevention of Cardiovascular Diseases in Tunisia", Tunis, Tunisia.

Aicha Hchaichi (A)

National Observatory of New and Emerging Diseases, Tunis, Tunisia.
Research laboratory "Epidemiology and Prevention of Cardiovascular Diseases in Tunisia", Tunis, Tunisia.

Chahida Harizi (C)

Department of Epidemiology and Statistics, Abderrahman Mami Hospital, Ariana, Tunisia.

Sonia Dhaouadi (S)

National Observatory of New and Emerging Diseases, Tunis, Tunisia.

Sondes Derouiche (S)

National Observatory of New and Emerging Diseases, Tunis, Tunisia.

Ilhem Bouaziz (I)

National Observatory of New and Emerging Diseases, Tunis, Tunisia.

Donia Gharbi (D)

National Observatory of New and Emerging Diseases, Tunis, Tunisia.

Nourhene Najar (N)

Department of Epidemiology and Public Health, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.

Molka Osman (M)

National Observatory of New and Emerging Diseases, Tunis, Tunisia.

Ines Cherif (I)

Department of Epidemiology and Public Health, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.

Rym Mlallekh (R)

Department of Epidemiology and Public Health, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.

Oumaima Ben-Ayed (O)

Department of Epidemiology and Public Health, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.

Yosr Ayedi (Y)

Department of Epidemiology and Public Health, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.

Leila Bouabid (L)

National Observatory of New and Emerging Diseases, Tunis, Tunisia.

Souha Bougatef (S)

National Observatory of New and Emerging Diseases, Tunis, Tunisia.

Nissaf Bouafif Ép Ben-Alaya (NBÉ)

National Observatory of New and Emerging Diseases, Tunis, Tunisia.
Research laboratory "Epidemiology and Prevention of Cardiovascular Diseases in Tunisia", Tunis, Tunisia.
Department of Epidemiology and Public Health, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.

Mohamed Kouni Chahed (MK)

Department of Epidemiology and Public Health, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH